Charting the importance of filamin A posttranslational modifications.
Kyle D SheadVeneta SalyahetdinovaGeorge S BailliePublished in: The Biochemical journal (2024)
Filamin A is an essential protein in the cell cytoskeleton because of its actin binding properties and unique homodimer rod-shaped structure, which organises actin into three-dimensional orthogonal networks imperative to cell motility, spreading and adhesion. Filamin A is subject to extensive posttranslational modification (PTM) which serves to co-ordinate cellular architecture and to modulate its large protein-protein interaction network which is key to the protein's role as a cellular signalling hub. Characterised PTMs include phosphorylation, irreversible cleavage, ubiquitin mediated degradation, hydroxylation and O-GlcNAcylation, with preliminary evidence of tyrosylation, carbonylation and acetylation. Each modification and its relation to filamin A function will be described here. These modifications are often aberrantly applied in a range of diseases including, but not limited to, cancer, cardiovascular disease and neurological disease and we discuss the concept of target specific PTMs with novel therapeutic modalities. In summary, our review represents a topical 'one-stop-shop' that enables understanding of filamin A function in cell homeostasis and provides insight into how a variety of modifications add an extra level of Filamin A control.
Keyphrases
- protein protein
- cardiovascular disease
- single cell
- small molecule
- cell therapy
- type diabetes
- binding protein
- squamous cell carcinoma
- coronary artery disease
- staphylococcus aureus
- stem cells
- escherichia coli
- metabolic syndrome
- young adults
- cystic fibrosis
- pseudomonas aeruginosa
- mesenchymal stem cells
- brain injury
- subarachnoid hemorrhage
- cardiovascular risk factors
- cerebral ischemia